Navigation Links
Einstein study reveals new approach for stopping herpes infections
Date:3/25/2013

March 25, 2013 (BRONX, NY) Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a novel strategy for preventing infections due to the highly common herpes simplex viruses, the microbes responsible for causing genital herpes (herpes simplex virus 2) and cold sores (herpes simplex virus 1). The finding, published online by The FASEB Journal, could lead to new drugs for treating or suppressing herpes virus infections.

"We've essentially identified the molecular "key" that herpes viruses use to penetrate cell membranes and infect cells of the human body," said Betsy Herold, M.D., professor of pediatrics (infectious diseases), of microbiology & immunology and of obstetrics & gynecology and women's health at Einstein and attending physician of pediatrics, The Children's Hospital at Montefiore.

Herpes viruses are known to infect skin cells as well as cells lining the cervix and the genital tract. A 2006 JAMA study estimates that nearly 60 percent of U.S. men and women between the ages of 14 and 49 carry the HSV-1 virus. The CDC estimates that about 1 in 6 Americans (16.2 percent) between 14 and 49 are infected with herpes simplex virus type 2 (HSV-2), according to a 2010 national health survey. HSV-2 is a lifelong and incurable infection that can cause recurrent and painful genital sores and can make those infected with the virus two-to-three times more likely to acquire HIV, the virus that causes AIDS.

Dr. Herold and her colleagues had previously shown that infection by the herpes viruses depends on calcium released within the cells. In this study, they found that calcium release occurs because the viruses activate a critical cell-signaling molecule called Akt at the cell membrane.

As part of their investigation of Akt's role in herpes infections, the researchers took laboratory cultures of those human cell types and mixed them for 15 minutes with four different drugs known to inhibit Akt. The cells were then exposed for one hour to herpes simplex virus 2. All four drugs significantly inhibited herpes virus infection in each of the cell types. By contrast, cells not pretreated with the Akt inhibitors were readily infected on exposure to the virus.

"For people infected with herpes, the drug acyclovir helps prevent herpes outbreaks from recurring and lowers the risk of transmitting the infection to others," said Dr. Herold. "But some people have herpes infections that don't respond to acyclovir, and unfortunately there is no effective vaccine. So new approaches for suppressing and treating herpes infections are badly needed, and our findings indicate that inhibiting Akt should be a useful therapeutic strategy to pursue."


'/>"/>

Contact: Kim Newman
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Related biology news :

1. Einstein receives $12 million grant to develop device for preventing HIV infection
2. Einstein researchers receive 2 Grand Challenges Explorations grants to combat HIV and TB
3. Feinstein Institute receives $1 million grant to study impact of World Trade Center attacks on responders
4. Einstein hosts its first stem cell institute symposium
5. Einstein researcher receives $10.8 million grant to study toxic blood reactions caused by hemoglobin
6. New lung cancer study takes page from Googles playbook
7. Study shows resources giveaway in Latin America; Outdated model tramples human rights, environment
8. Scientists awarded £3M to study the way Northwest European seas absorb carbon
9. Additional research must be done to ensure safety of pit latrines, new study says
10. UF fossil bird study on extinction patterns could help todays conservation efforts
11. Do I know you? Memory patterns help us recall the social webs we weave, finds new Cornell study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/8/2019)... ... September 06, 2019 , ... ... human mesenchymal stem/stromal cell (hMSC) biomanufacturing systems, today announces its release of ... and media system designed for product development. RoosterBio continues to simplify MSC ...
(Date:8/29/2019)... , ... August 28, 2019 , ... Lajollacooks4u has expanded ... Diego-based team building and cooking events company has seen record growth in 2019, having ... as Amazon, ServiceNow, Vistage and Illumina, have all visited the company’s La Jolla-based venue, ...
(Date:8/27/2019)... ... August 27, 2019 , ... Ambry Genetics ... genetic testing guidelines. In the largest cohort study of its kind, Ambry presents ... patients. , Clinicians use guidelines to inform decisions about which patients should ...
Breaking Biology News(10 mins):
(Date:8/27/2019)... ... August 27, 2019 , ... ... pleased to announce it has promoted Consulting Engineer, Robert Battista, to Senior Consulting ... the responsibility of onboarding and mentoring new engineers as well as the creation ...
(Date:8/15/2019)... (PRWEB) , ... August 15, 2019 , ... ... Scientific Advisory Board. Mr. Lawrence is a member of the Institute of Food ... Safety and Health (IFSH) Advisory Board, Joint Institute for Food Safety and Applied ...
(Date:8/7/2019)... ... August 07, 2019 , ... Locus Agricultural Solutions (Locus AG) reports record ... (soil “probiotics”), including Rhizolizer ® , which is pulling up to 121% more ... has offered to date. Results from the treatment of almonds, cherries, turf/sod, grapes and ...
(Date:8/6/2019)... Ill. (PRWEB) , ... August 06, 2019 , ... ... Southern Illinois University Edwardsville for the launch of a community project that will ... The three-year grant supports the project, entitled “A Youth-Led Citizen Science Network for ...
Breaking Biology Technology: